<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://wikem.org/w/index.php?action=history&amp;feed=atom&amp;title=Zoledronate</id>
	<title>Zoledronate - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://wikem.org/w/index.php?action=history&amp;feed=atom&amp;title=Zoledronate"/>
	<link rel="alternate" type="text/html" href="https://wikem.org/w/index.php?title=Zoledronate&amp;action=history"/>
	<updated>2026-04-16T00:45:40Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.38.2</generator>
	<entry>
		<id>https://wikem.org/w/index.php?title=Zoledronate&amp;diff=225728&amp;oldid=prev</id>
		<title>ClaireLewis: Created page with &quot;==Administration== *Type: Bisphosphonate *Dosage Forms: *Routes of Administration: IV *Common Trade Names:   ==Adult Dosing== *4mg IV once, may repeat in 7d  ==Pediatric Dosin...&quot;</title>
		<link rel="alternate" type="text/html" href="https://wikem.org/w/index.php?title=Zoledronate&amp;diff=225728&amp;oldid=prev"/>
		<updated>2019-08-24T21:10:47Z</updated>

		<summary type="html">&lt;p&gt;Created page with &amp;quot;==Administration== *Type: Bisphosphonate *Dosage Forms: *Routes of Administration: IV *Common Trade Names:   ==Adult Dosing== *4mg IV once, may repeat in 7d  ==Pediatric Dosin...&amp;quot;&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;==Administration==&lt;br /&gt;
*Type: Bisphosphonate&lt;br /&gt;
*Dosage Forms:&lt;br /&gt;
*Routes of Administration: IV&lt;br /&gt;
*Common Trade Names: &lt;br /&gt;
&lt;br /&gt;
==Adult Dosing==&lt;br /&gt;
*4mg IV once, may repeat in 7d&lt;br /&gt;
&lt;br /&gt;
==Pediatric Dosing==&lt;br /&gt;
''Safety/efficacy not established''&lt;br /&gt;
&lt;br /&gt;
==Special Populations==&lt;br /&gt;
===[[Drug pregnancy categories|Pregnancy Rating]]===&lt;br /&gt;
*Pregnancy category D&lt;br /&gt;
&lt;br /&gt;
===Lactation risk===&lt;br /&gt;
*No information available, avoid use or breastfeeding&lt;br /&gt;
&lt;br /&gt;
===Renal Dosing===&lt;br /&gt;
*Adult:&lt;br /&gt;
**CrCl 50-60 mL/min: 3.5 mg&lt;br /&gt;
**CrCl 40-49 mL/min: 3.3 mg&lt;br /&gt;
**CrCl 30-39 mL/min: 3 mg&lt;br /&gt;
**CrCl &amp;lt;30 mL/min: Not recommended&lt;br /&gt;
&lt;br /&gt;
===Hepatic Dosing===&lt;br /&gt;
''Safety/efficacy not established''&lt;br /&gt;
&lt;br /&gt;
==Contraindications==&lt;br /&gt;
*Allergy to class/drug&lt;br /&gt;
*Hypocalcemia&lt;br /&gt;
*Severe renal impairment (CrCl &amp;lt;35 mL/min or evidence of acute renal impairment)&lt;br /&gt;
**Rehydrate hypovolemic patients prior to administration&lt;br /&gt;
&lt;br /&gt;
==Adverse Reactions==&lt;br /&gt;
===Serious===&lt;br /&gt;
*Hypocalcemia&lt;br /&gt;
*Bronchoconstriction if aspirin-sensitive asthma&lt;br /&gt;
*Osteonecrosis (usually of jaw)&lt;br /&gt;
*Acquired fanconi syndrome&lt;br /&gt;
*Hypotension&lt;br /&gt;
&lt;br /&gt;
===Common===&lt;br /&gt;
*Bone pain, arthralgia&lt;br /&gt;
*Nausea/vomiting, constipation, diarrhea&lt;br /&gt;
*Fever&lt;br /&gt;
*Fatigue, insomnia, anxiety&lt;br /&gt;
*Anemia&lt;br /&gt;
*Dyspnea&lt;br /&gt;
*Headache, dizziness&lt;br /&gt;
*UTI&lt;br /&gt;
*Hypophosphatemia, hypokalemia, hypomagnesemia&lt;br /&gt;
*Rash&lt;br /&gt;
&lt;br /&gt;
==Pharmacology==&lt;br /&gt;
*Half-life: 146h&lt;br /&gt;
*Metabolism: Not metabolized&lt;br /&gt;
*Excretion: Urinary&lt;br /&gt;
&lt;br /&gt;
==Mechanism of Action==&lt;br /&gt;
*Acts on osteoclasts to inhibit bone resorption&lt;br /&gt;
&lt;br /&gt;
==Comments==&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==See Also==&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
https://reference.medscape.com/drug/reclast-zometa-zoledronic-acid-342858#10&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Category:Pharmacology]]&lt;/div&gt;</summary>
		<author><name>ClaireLewis</name></author>
	</entry>
</feed>